Silicon Valley’s Agilent Technologies buys Cartagenia

May 5, 2015 News BioVox

Cartagenia, established in 2008 as a spin-off from the University of Leuven, has been taken over by the American company, Agilent Technologies. Cartagenia develops analytical software for molecular labs, doctors and hospitals. The companies did not reveal any financial details.

Agilent Technologies, headquartered in Santa Clara, California, is a spin-off from Hewlett Packard. Last year, the company had 12.000 employees and realized a turnover of $4 billion. Agilent specializes in lab technology, with applications in food, environment, energy, pharmaceuticals, research and diagnostic industries.

Cartagenia will become a business unit within the Genomics and Diagnostics Group at Agilent. Cartagenia CEO Herman Verrelst remains head of that division and will continue to develop new innovations. The 37 employees of the company will carry on with their job. Eight of them will start to work in the US office in Boston.


Avatar photo
BioVox

With a local focus and global reach, the news platform BioVox shares insights into the Benelux life sciences ecosystem with readers across the world. BioVox is an independent publisher, providing its community with quality content and first-row access to interesting breakthroughs and trends in biotech, medtech, agtech, pharma, and more. We shine a spotlight on the latest news and innovations from both our partners and community.

All posts

Subscribe to the BioVox newsletter